哮喘联盟

   摘要
   背景：一项新的、公共卫生有效数据信息集 (HEDIS)哮喘护理质量评估项目已经实施，这项评估旨在量化病人对哮喘控制药物的依从性。这项评估与哮喘结果之间的关系尚不明确。
   目的：旨在调查对于哮喘患者，HEDIS药物治疗（MMA）评估与哮喘结果的关系。
   方法：管理数据纳入了2012年符合HEDIS标准的持续性哮喘患者30,040名。根据75%阈值和50%阈值，将这些患者分为MMA评估依从与不依从。测定2012年MMA依从性与2013年哮喘结果的关联。
   结果：与不依从患者相比，2012年75%MMA依从和50%MMA依从的患者在2013年与哮喘相关的住院、急诊和抢救性吸入剂使用率上无临床意义上的差别。分组比较MMA依从高于75%，MMA依从为50%-74%，MMA依从低于50%的患者，各组哮喘的结果无明显差异。
   结论：HEDIS MMA评估得到的依从性与哮喘结果改善（抢救性吸入剂使用、因哮喘住院治疗、因哮喘急诊）无关。
 

（苏欣 审校）
JAllergyClinImmunolPract. 2015Mar7.pii:S2213-2198(15)00051-3.doi:10.1016/j.jaip.2015.02.002. [Epub ahead of print]

 

The HEDIS Medication Management for People With Asthma Measure is Not Related to Improved Asthma Outcomes.
 

Crans Yoon A1, Crawford W2, Sheikh J3, Nakahiro R4, Gong A5, Schatz M4.

Author information
 

ABSTRACT
BACKGROUND:A new Healthcare Effectiveness Data and Information Set (HEDIS) asthma quality-of-care measure designed to quantify patient adherence to asthma controller medication has been implemented. The relationship between this measure and asthma outcomes is unknown.
OBJECTIVE:To examine the relationship between the HEDIS Medication Management for people withAsthma (MMA) measure and asthma outcomes.
METHODS:Administrative data identified 30,040 patients who met HEDIS criteria for persistent asthmaduring 2012. These patients were classified as compliant or noncompliant with the MMA measure at the 75% and 50% threshold, respectively. The association between MMA compliance in 2012 and asthmaoutcomes in 2013 was determined.
RESULTS:Patients who were 75% or 50% MMA compliant in 2012 showed no clinically meaningful difference in asthma-related hospitalizations, emergency department visits, or rescue inhaler dispensing in 2013 compared with those who were noncompliant. Stepwise comparison of patients who were 75% or more, 50% to 74%, and less than 50% MMA compliant showed no meaningful difference in asthmaoutcomes between groups.
CONCLUSIONS:Compliance with the HEDIS MMA measure is not related to improvement in theasthma outcomes assessed (rescue inhaler dispensing, asthma-coded hospitalizations, or asthma-coded emergency department visits).
 

JAllergyClinImmunolPract. 2015Mar7.pii:S2213-2198(15)00051-3.doi:10.1016/j.jaip.2015.02.002. [Epub ahead of print]